Stein_General_0.png

Welcome to ADAA's Professional Community

ADAA is the only multidisciplinary professional organization in mental health that engages the world’s leading experts who focus on anxiety, depression and co-occurring disorders. Engaging a membership of more than 1,800 professionals, ADAA strives to improve patient care by promoting implementation of evidence-based treatments and best practices across disciplines through trainings, continuing education and accelerating dissemination of research into practice.

  ADAA promotes scientific innovation and engages a diverse network of clinicians and basic and clinical anxiety and depression researchers with diverse backgrounds in medicine, psychology, social work, counseling, nursing, neuroscience, genetics, epidemiology, and other disciplines to advance science and new treatments. 

⇒  ADAA member dues help support the free information and resources that are provided to the more than 38 million annual website visitors to www.adaa.org. Membership dues also help fund the research that will one day prevent and cure anxiety, depression and related disorders. 

Member News and Program Updates

“There are definitely some changes to the modern workplace that can increase stress and exacerbate depression and anxiety," says ADAA member Stephen Schueller, PhD in this article on dealing with anxiety and depression in IT workplaces. 
ADAA members Adam Kaplin, MD, PhD and Alan Schatzberg, MD are featured in this article about ketamine and opioids. 
"The “unknown” is anxiety provoking for just about everyone. So how will this upcoming school year be for our teens? We don't know, and neither do they. Rightfully so, this time of year can generate lots of emotions; feelings of happiness for new school supplies, reuniting with friends and some new back to school clothes, but it can also bring up feelings of fear." ADAA member Dominique Apollon, MA, LPC, NCC authors this new blog post on back to school anxiety. 
ADAA member Ned Kalin, MD is featured in this article on his team's study on a brain molecule's impact on the anxiety model.